🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MSC2490484A is an investigational drug that is being evaluated for the trea...
Status
Completed
Location
Institut Jules Bordet
Start Date
2014-12-31
Trial ID
NCT02316197
Treatments Being Tested
M3814 is an investigational drug under evaluation for treatment of lung can...
Status
Terminated
Location
Research site
Start Date
2017-05-25
Trial ID
NCT03116971
This phase I/II trial studies the safety, side effects and best dose of M38...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-01-11
Trial ID
NCT04172532
This phase I trial tests the safety, side effects and best dose of peposert...
Status
Recruiting
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2024-06-07
Trial ID
NCT05687136
This proof-of-concept platform trial is designed to cover the targeting of ...
Status
Recruiting
Location
Rigshospitalet
Start Date
2016-08-03
Trial ID
NCT02813135
This phase I/II trial studies the best dose of M3814 when given together wi...
Status
Suspended
Location
City of Hope Comprehensive Cancer Center
Start Date
2020-10-14
Trial ID
NCT04071236
This phase I trial investigates the side effects and best dose of Peposerti...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-09-20
Trial ID
NCT04555577
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of combina...
Status
Recruiting
Location
Los Angeles General Medical Center
Start Date
2024-02-06
Trial ID
NCT05711615
This is an open label, single-arm, multicentre dose escalation (Part 1) and...
Status
Recruiting
Location
Macquarie University
Start Date
2023-05-23
Trial ID
NCT05868174
Treatments Being Tested
M3814 was an investigational drug that is being evaluated for the treatment...
Status
Completed
Location
Research site
Start Date
2015-09-15
Trial ID
NCT02516813
Treatments Being Tested